Skip to main content

University of Birmingham’s Professor Pamela Kearns has been announced as a Trustee and Member of Cancer Research UK.

Professor Kearns is Chair of clinical paediatric oncology at the University of Birmingham and an honorary consultant paediatric oncologist at Birmingham Women and Children’s Hospital. She is director of the University of Birmingham’s Institute of Cancer and Genomic Sciences and director of the Cancer Research UK Clinical Trials Unit (CRCTU).

As director of CRCTU, Professor Kearns leads the research strategy for one of UK's largest cancer trials units, delivering a trials portfolio of more than 100 multi-centre and international cancer trials for a wide range of cancers occurring in children, young people and adults.

Professor Kearns was elected president of the European Society of Paediatric Oncology in 2019, having been a board member since 2013. She holds several European roles including executive board member of the academic consortium Innovative Therapeutics in Childhood Cancer (ITCC), Chair of ITCC’s European sponsor institutions committee and is a steering committee member of the international multi-stakeholder platform ACCELERATE.

Her research interests are focused on drug development and innovation of design and delivery of clinical trials for childhood cancers. Professor Kearns was also a senior clinical advisor to Cancer Research UK from 2015 to 2020 and is a trustee of a Child of Mine, a charity dedicated to supporting bereaved parents.

Professor Kearns, of the University of Birmingham’s College of Medical and Dental Sciences, said: “It is a real privilege to serve as a Trustee for Cancer Research UK and I am looking forward to supporting the charity in delivering its mission to transform the care of patients with cancer and to ‘beat cancer sooner’.”

Sir Leszek Borysiewicz, Chair of Cancer Research UK, said: “I’m very happy to welcome Pam to our Governing Council. She brings an exceptional knowledge of cancer research through her broad experience and commitment to her work in the field. I look forward to working with her more closely.”

All Trustee roles at Cancer Research UK are unremunerated.

Note to editors:

For more information, please contact:

  1. Emma McKinney, Communications Manager, University of Birmingham, on +44 7815607157. Alternatively, contact the Press Office out of hours on +44 (0)7789 921165.
  2. Cancer Research UK press office on 020 3469 8300.

About the University of Birmingham

  • The University of Birmingham is ranked amongst the world’s top 100 institutions, and its work brings people from across the world to Birmingham, including researchers and teachers and more than 6,500 international students from nearly 150 countries.

About Cancer Research UK

  • Cancer Research UK is the world’s leading cancer charity dedicated to saving lives through research.
  • Cancer Research UK’s pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.
  • Cancer Research UK has been at the heart of the progress that has already seen survival in the UK double in the last 40 years.
  • Today, 2 in 4 people survive their cancer for at least 10 years. Cancer Research UK’s ambition is to accelerate progress so that by 2034, 3 in 4 people will survive their cancer for at least 10 years.
  • Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
  • Together with its partners and supporters, Cancer Research UK's vision is to bring forward the day when all cancers are cured.
  • For further information about Cancer Research UK's work or to find out how to support the charity, please call 0300 123 1022.